ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...

PORTLAND, Ore.—Omnicare Inc., a subsidiary of CVS Health and a provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by, among other things, allowing opioids and other controlled substances to be...

MILWAUKEE - DEA Assistant Special Agent in Charge Paul E. Maxwell and United States Attorney Matthew D. Krueger announced today that Dr. Mehran Heydarpour of Brookfield, Wisconsin, agreed to pay $175,000 to resolve allegations that he prescribed opioid pain medications in violation of the Controlled Substances Act and that he...

ST. LOUIS – Angela K. Williams, M.D., 34, of Brentwood, Missouri, pleaded guilty today to one felony charge of fraudulently obtaining oxycodone, a narcotic opioid prescription drug. This case was investigated by the Drug Enforcement Administration St. Louis Division, the Florissant Police Department, the Town and Country Police Department, and...

URBANA, Ill. – U.S. District Judge Michael M. Mihm today sentenced a Champaign, ll., man, Stephan Caamano, to 13 years in federal prison for trafficking at least 4.3 million counterfeit Xanax pills throughout the country and laundering the proceeds. Caamano has been ordered to pay more than $2.1 million he...

HONOLULU – The United States Drug Enforcement Administration in Honolulu urges its DEA-registered practitioners to be cautious of telephone calls from criminals posing as DEA agents or other law enforcement personnel demanding the practitioner provide their DEA-registrant number and other practitioner-related sensitive information over the telephone. Most recently, the DEA...

LOUISVILLE, Ky. - The United States Drug Enforcement Administration today announced that it will be hosting a regional Practitioner Diversion Awareness Conference (PDAC) on March 27, 2019. The PDAC is designed to educate and assist doctors, veterinarians, dentists, physician assistants, and nurse practitioners across the Commonwealth of Kentucky in identifying...

WASHINGTON, D.C. - The U.S. Drug Enforcement Administration today released the 2017 edition of Drugs of Abuse, A DEA Resource Guide. The Drugs of Abuse guide is released on a periodic basis and designed to be a reliable resource on the most commonly abused and misused drugs in the United...

WASHINGTON - Hundreds of thousands of counterfeit prescription pills, many containing deadly amounts of fentanyl and fentanyl-related compounds, have made their way into the U.S. drug market, according to a DEA intelligence report released today. Law enforcement nationwide report higher fentanyl availability, seizures, and known overdose deaths than at any...